PM411. Evaluation of Paliperidone Palmitate Long-Acting Injectable Therapy by Duration of Illness in Patients With Schizophrenia

Gelijkaardige items

• Evaluation of paliperidone palmitate long‐acting injectable antipsychotic therapy as an early treatment option in patients with schizophrenia
  door: Brown, Brianne, et al.
  Gepubliceerd in: (2019)
• Paliperidone Palmitate Improves and Maintains Functioning in Asia–Pacific Patients with Schizophrenia
  door: Zhang, Hongyan, et al.
  Gepubliceerd in: (2017)
• Methodological challenges in indirect treatment comparisons: spotlight on a recent comparison of long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia
  door: Singh, Arun, et al.
  Gepubliceerd in: (2018)
• S203. EFFECT OF LONG-ACTING INJECTIONS OF PALIPERIDONE PALMITATE ON CLINICAL AND FUNCTIONAL OUTCOMES IN PATIENTS WITH SCHIZOPHRENIA BASED ON ILLNESS DURATION
  door: Kim, Seoyoung, et al.
  Gepubliceerd in: (2020)
• Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulation
  door: Nash, Abigail I, et al.
  Gepubliceerd in: (2019)